Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.
Krista F HuybrechtsBrian T BatemanSonia Hernández-DíazPublished in: Pharmacoepidemiology and drug safety (2019)
The approaches presented provide guidance regarding the important methodological considerations that need to be attended to in order to generate valid, minimally biased risk when using large healthcare utilization databases for drug safety surveillance in pregnancy.